Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155)

S. Aliberti, L. C. Morlacchi, F. Giuliani, P. Peyrani, T. Wiemken, V. Valenti, L. Pancini, A. Voza, E. Parazzini, P. Rossi, D. Stolz, D. Legnani, E. Magni, L. Richeldi, R. Fantini, V. Monzani, R. Cosentini, G. Bonaiti, G. Suigo, P. Faverio, A. Pesci, J. Ramirez, F. Blasi (Milan, Rozzano (MI), Udine, Modena, Italy; Louisville, United States Of America; Basel, Switzerland)

Source: International Congress 2014 – Immunology of respiratory infections

Session: Immunology of respiratory infections
Session type: Oral Presentation
Number: 485

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Aliberti, L. C. Morlacchi, F. Giuliani, P. Peyrani, T. Wiemken, V. Valenti, L. Pancini, A. Voza, E. Parazzini, P. Rossi, D. Stolz, D. Legnani, E. Magni, L. Richeldi, R. Fantini, V. Monzani, R. Cosentini, G. Bonaiti, G. Suigo, P. Faverio, A. Pesci, J. Ramirez, F. Blasi (Milan, Rozzano (MI), Udine, Modena, Italy; Louisville, United States Of America; Basel, Switzerland). Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155). Eur Respir J 2014; 44: Suppl. 58, 485

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
"Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP)) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
LATE-BREAKING ABSTRACT: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014
Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014